James S. Hewlett
- Hematology top 1%
- Acute Myeloid Leukemia Research 11
- Hematopoietic Stem Cell Transplantation 4
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 6
- Oncology top 5%
- Neutropenia and Cancer Infections 6
-
- Lymphoma Diagnosis and Treatment 5
- Immunology top 10%
-
- Acute Lymphoblastic Leukemia research 9
-
- Erythrocyte Function and Pathophysiology 4
-
- Cancer therapeutics and mechanisms 4
- Co-authors
- Raymond W. MontoEdmund A. GehanRonald M. BukowskiMontague LaneArthur HautRaymond AlexanianEmil FreiJohn D. Bonnet
- Cited by
- HematologyGeneticsOncology
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
James S. Hewlett
52 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 106
- Hematology 812
- Genetics 284
- Oncology 668
- Pathology and Forensic Medicine 282
- Immunology 218
Countries citing papers authored by James S. Hewlett
This map shows the geographic impact of James S. Hewlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James S. Hewlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James S. Hewlett more than expected).
Fields of papers citing papers by James S. Hewlett
This network shows the impact of papers produced by James S. Hewlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James S. Hewlett. The network helps show where James S. Hewlett may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James S. Hewlett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [The etiology of Kaposi's sarcoma]. | 1991 | 4 |
| 2 | 1989 | 28 | |
| 3 | 1988 | 14 | |
| 4 | 1988 | 101 | |
| 5 | 1983 | 23 | |
| 6 | 1983 | 14 | |
| 7 | 1982 | 8 | |
| 8 | Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study. | 1982 | 104 |
| 9 | Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study. | 1981 | 11 |
| 10 | 1981 | 77 | |
| 11 | 1979 | 23 | |
| 12 | 1977 | 26 | |
| 13 | 1977 | 3 | |
| 14 | 1975 | 182 | |
| 15 | Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults. | 1969 | 87 |
| 16 | 1965 | 3 | |
| 17 | 1960 | 71 | |
| 18 | 1957 | 25 | |
| 19 | 1954 | 41 | |
| 20 | 1953 | 3 |
About James S. Hewlett
James S. Hewlett is a scholar working on Hematology, Genetics, Oncology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 53 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (9 papers), Chronic Lymphocytic Leukemia Research (6 papers), Neutropenia and Cancer Infections (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Erythrocyte Function and Pathophysiology (4 papers), Cancer therapeutics and mechanisms (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Hematology (812 citations), Genetics (284 citations), Oncology (668 citations), Pathology and Forensic Medicine (282 citations) and Immunology (218 citations). James S. Hewlett has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Raymond W. Monto, Edmund A. Gehan, Ronald M. Bukowski, Montague Lane, Arthur Haut, Raymond Alexanian, Emil Frei, John D. Bonnet, Henry E. Wilson and Robert W. Talley. Their work appears in journals such as Cancer, Blood, American Journal of Clinical Pathology, Transfusion and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.